Evidence map›Paper›PMID 39954209›Full record

ArticleInfection2025

Microbiological diversity among patients with Lemierre syndrome and clinical implications: an individual patient-level analysis.

Maurus Frehner, Riccardo M Fumagalli, Silvio D Brugger, Silvia Cardi, Filippo Catalani, Alice Trinchero, Alessandro Pecci, Nils Kucher, Luca Valerio, Stefano Barco

Abstract read
In one paragraph

Article in Infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Lemierre syndrome.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maurus FrehnerDepartment of Angiology, University Hospital Zurich, Zurich, Switzerland.
Riccardo M FumagalliDepartment of Angiology, University Hospital Zurich, Zurich, Switzerland.
Silvio D BruggerDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Silvia CardiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Filippo CatalaniDepartment of Angiology, University Hospital Zurich, Zurich, Switzerland.
Alice TrincheroDepartment of Medical Oncology and Haematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Alessandro PecciDepartment of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy.
Nils KucherDepartment of Angiology, University Hospital Zurich, Zurich, Switzerland.
Luca ValerioDepartment of Cardiology, University Medical Center Mainz, Mainz, Germany. luca.valerio@uni-mainz.de.
Stefano BarcoDepartment of Angiology, University Hospital Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLemierre syndrome is a rare condition traditionally defined by bacterial infection of the head/neck region, local thrombophlebitis, and septic embolism. Although in most cases Fusobacterium necrophorum is isolated, it is questionable whether the presence of this microbe is mandatory for diagnosis. In this study, we investigated microorganisms isolated in cases of Lemierre syndrome and their association with demographical and clinical features.

methodsWe conducted an analysis of individual patient data from 712 patients diagnosed with Lemierre syndrome. Demographics, clinical presentation, treatment strategies, and outcomes according to different pathogens were evaluated.

resultsAmong a total of 712 patients, in 574 cases bacterial growth was detected. In 415 patients Fusobacterium spp. was isolated, in 108 either Streptococcus spp. or Staphylococcus spp., and in 51 other bacteria. Patients with different bacteria differed markedly in age, site of preceding infections, clinical presentation, and treatment. Fusobacterium spp. was typically isolated in younger patients (69% of patients aged 16 to 30 years) while Streptococcus spp. and Staphylococcus spp. were more prevalent in older subjects (30% of patients aged over 45 years). Of all cases with Fusobacterium spp., 63% had a thrombosis of the internal jugular vein and 91% septic embolism, compared with 94% and 69%, respectively, in cases with Streptococcus spp. or Staphylococcus spp.

conclusionIn contrast to the available literature, our study suggests that Lemierre syndrome may be caused by multiple bacterial species, and that the clinical presentation and course may vary according to the specific bacterial species involved.

Indexed as

BacteriaLemierre SyndromeAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleFusobacterium InfectionsFusobacterium necrophorumHumansMaleMiddle AgedStreptococcusYoung AdultFusobacteriumInfectious diseaseLemierre syndromeSeptic embolismStaphylococcusThrombosis

Identifiers

PMID39954209
PMCPMC12460448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.